HC-070 decreases anxiety after CCK-4 treatment in an EPM. by Stefan Just (4811358)

Figure S1 - VILIP-1 Expression <em>In Vivo</em> Results in Decreased Mouse Skin Keratinocyte Proliferation and Tumor Development by Jian Fu (41067)

c1 dKI mice have decreased CD4, T_fh, and IFNγ-producing T cells. by Kieran P. Manion (9179139)

Decreased phosphorylation of GSK3β-Ser9 in thrombin stimulated PP1cγ^−/− platelets. by Francisca C. Gushiken (368549)

“…Data are expressed as ±SEM of 5 experiments. (<b>D</b>) Effect of GSK3β inhibitor VIII on thrombin-induced fibrinogen binding on WT and PP1cγ^−/− platelets. …”

zQ175 mice displayed progressive motor deficits on balance beam and decreased locomotor activity in the Open Field chambers. by Qi Peng (702503)

<i>Cdkl5</i> -/Y mice show an increased freezing time and a decreased distance traveled during the pretone period in the altered context. by Kosuke Okuda (5150393)

“…<i>Cdkl5</i> -/Y mice show a significantly decreased distance traveled in response to the first footshock (p = 0.0158) compared with control mice. …”

Blocking VIP-signaling increased expression of costimulatory molecules and decreased expression of coinhibitory molecules on lymphocytes following mCMV infection. by Jian-Ming Li (319425)

a-c: Proximal tibia (PT) EPO receptor (EPO-R) decreases in uremic rats, as shown by Western blot (Fig. 5a) and immunohistochemistry (Fig. 5b). by Daniel Landau (440830)

“…Animals received a single bolus of IV rhEPO (25 U/kg) or saline, 5 minutes prior to sacrifice. …”

Pharmacological inhibition of EGFR decreases early fungal burden and reduces the inflammatory response. by Marc Swidergall (185453)

Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

“…Kidney angiomyolipomas regrew when sirolimus was discontinued but responses tended to persist if treatment was continued after week 52. We observed regression of brain tumors (SEGAs) in 7/11 cases (26% mean decrease in diameter), regression of liver angiomyolipomas in 4/5 cases (32.1% mean decrease in longest diameter), subjective improvement in facial angiofibromas in 57%, and stable lung function in women with TSC/LAM (n = 15). …”

Decreased expression of <i>catp-3</i> underlies compromised tolerance to oxidative stress in <i>shk-1</i> mutants. by Longjun Pu (20685717)

MCU is required for normal presynaptic Ca²⁺ clearance and MCU expression is decreased in LKB1-null hippocampi. by Seok-Kyu Kwon (3151941)

Establishing environmental soil phosphorus thresholds to decrease the risk of losses to water in soils from Rio Grande do Sul, Brazil by Luciano Colpo Gatiboni (4619761)

Decreased recruitment of NK, CD4+ and CD8+ T cells in HSV-2 infected Fas and FasL-deficient mice. by Malgorzata Krzyzowska (587002)

DataSheet_1_Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages.pdf by Cassandra L. R. van Doorn (11388245)

DataSheet_4_Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages.pdf by Cassandra L. R. van Doorn (11388245)

DataSheet_3_Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages.pdf by Cassandra L. R. van Doorn (11388245)

DataSheet_2_Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages.pdf by Cassandra L. R. van Doorn (11388245)

The 11R-VIVIT peptide inhibitor of NFATs decreases bacterial phagocytic killing capacity by neutrophils and increases renal susceptibility to UPEC. by Emilie Tourneur (278826)

FFA treatment for 48 hours induced decrease of IFNAR1 in Huh-7.5 cells is mediated by a lysosomal degradation pathway. by Ramazan Kurt (449801)